Kryštof Vladimír

Journals

OPITZ, A., L. SEITZ, V. KRYŠTOF, F. BASELIOUS, M. HOLZER, W. SIPPL, A. HILGEROTH
Novel effective small-molecule inhibitors of protein kinases related to tau pathology in Alzheimer's disease. Future Medicinal Chemistry. 2022, 14(16), 1175-1186, ISSN: 1756-8919, PMID: 35920260,
JORDA, R., L. HAVLÍČEK, M. PERINA, V. VOJÁČKOVÁ, T. POSPÍŠIL, S. DJUKIC, J. SKERLOVA, J. GRÚZ, N. RENESOVA, P. KLENER, P. ŘEZÁČOVÁ, M. STRNAD, V. KRYŠTOF
3,5,7-Substituted Pyrazolo[4,3- d]Pyrimidine Inhibitors of Cyclin-Dependent Kinases and Cyclin K Degraders. Journal of Medicinal Chemistry. 2022, 65(13), 8881-8896, ISSN: 0022-2623, PMID: 35749742,
BERTRAND, J., H. DOSTÁLOVÁ, V. KRYŠTOF, R. JORDA, T. DELGADO, A. CASTRO-ALVAREZ, J. MELLA, D. CABEZAS, M. FAUNDEZ, C. ESPINOSA-BUSTOS, O. SALAS C.
Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia. Pharmaceutics. 2022, 14(6), 1294, ISSN: 1999-4923, PMID: 35745866,  PDF.